About Anapa Biotech
Anapa Biotech is a company based in Hvidovre (Denmark) founded in 2002. Anapa Biotech has raised $1 million across 1 funding round from investors including Vecata. The company has 2 employees as of March 31, 2024. Anapa Biotech offers products and services including MeltPlex® multiplex PCR and Nucleic Acid Assays. Anapa Biotech operates in a competitive market with competitors including Arcis Biotechnology, Scipio Bioscience, SciGenom, MicroGEM and Seevix, among others.
- Headquarter Hvidovre, Denmark
- Employees 2 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Anapa Biotech A/S
-
Annual Revenue
Not available
-
Net Profit
-$571.73 K (USD)-450as on Dec 31, 2019
-
EBITDA
Not available
-
Total Equity Funding
$1 M (USD)
in 1 rounds
-
Latest Funding Round
$1 M (USD), Series A
Jan 25, 2007
- Investors
-
Employee Count
2
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Anapa Biotech
Anapa Biotech offers a comprehensive portfolio of products and services, including MeltPlex® multiplex PCR and Nucleic Acid Assays.
Enables high throughput PCR for multiple diagnostic assays.
Supports advanced molecular testing in scientific and environmental fields.
Funding Insights of Anapa Biotech
Anapa Biotech has successfully raised a total of $1M through 1 strategic funding round. The most recent funding activity was a Series A round of $1 million completed in January 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Anapa Biotech
Anapa Biotech has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Vecata.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Anapa Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Anapa Biotech
Investment portfolio details for Anapa Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Anapa Biotech
Detailed financials for Anapa Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Anapa Biotech Comparisons
Peer comparison for Anapa Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Anapa Biotech
Anapa Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Arcis Biotechnology, Scipio Bioscience, SciGenom, MicroGEM and Seevix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider and developer of reagent kits and technology for genome isolation and amplification
|
|
| Locked | Locked | Locked |
Sample preparation kits for single-cell sequencing studies are developed.
|
|
| Locked | Locked | Locked |
Provider of genome sequencing and bioinformatics services life science and healthcare sector
|
|
| Locked | Locked | Locked |
Produces high-quality nucleic acid extractors and laboratory kits.
|
|
| Locked | Locked | Locked |
Genetically engineered spider silk fibers are produced for industrial uses.
|
|
| Locked | Locked | Locked |
Ferrofluidic nanomaterials are developed for biomedical and magnetic applications.
|
Detailed competitors of Anapa Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Anapa Biotech
Complete news archive for Anapa Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anapa Biotech
Anapa Biotech was founded in 2002 and raised its 1st funding round 5 years after it was founded.
Anapa Biotech is headquartered in Hvidovre, Denmark.
Soren Morgenthaler Echwald is the current CEO of Anapa Biotech.
Anapa Biotech is a funded company, having raised a total of $1M across 1 funding round to date.
As of Mar 31, 2024, the latest employee count at Anapa Biotech is 2.
Anapa Biotech was founded in 2002 in Hvidovre, Denmark, within the biotechnology sector. Proprietary Twisted Intercalating Nucleic Acid (TINA) molecules are developed to improve the thermal stability of duplex, triplex, and quadruplex helixes. These tools are applied in PCR-based assays and hybridization processes to support nucleic acid performance. Operations focus on molecular enhancements for research and diagnostic applications.
Anapa Biotech's top competitors include Arcis Biotechnology, SciGenom and Scipio Bioscience.
Anapa Biotech offers MeltPlex® multiplex PCR and Nucleic Acid Assays.
Anapa Biotech has 1 investor. Key investors include Vecata.